Highly Potent Drugs

Feb 13, 2018
By Pharmaceutical Technology Editors
Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification.
Feb 01, 2018
By Pharmaceutical Technology Editors
Cambrex invests in development and laboratory facilities and adds staff.
Jan 25, 2018
By Pharmaceutical Technology Editors
Hovione has installed a new MG2 Tekna Precision Capsule filler at its Portugal site.
Oct 02, 2017
Pharmaceutical Technology
CDMOs have established strategies for handling new chemical entities with unknown biological activity.
Aug 10, 2017
By Pharmaceutical Technology Editors
Cambrex is investing $24 Million in new, highly potent API manufacturing capacity at its Charles City, Iowa site.
Aug 03, 2017
By Pharmaceutical Technology Editors
CordenPharma is investing €10 Million in a new line at its Plankstadt, Germany site.
Jul 19, 2017
By Pharmaceutical Technology Editors
ChargePoint Technology is expanding its US presence by opening a new office in San Francisco.
Jul 03, 2017
By Pharmaceutical Technology Editors
The Spanish CDMO has installed a new automatic capsule filling machine at its EU GMP-approved plant in Pamplona, Spain
Jun 06, 2017
By Pharmaceutical Technology Editors
Takeda will build a new production facility at its existing Grange Castle site in Ireland.
May 30, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
BioVectra will open its new microbial fermentation and complex chemistry site, including the capability to handle high-potency APIs, by the end of 2017.
native1_300x100
lorem ipsum